Lastly, our observation that estrogen signaling in the luminal progenitors does not increase the expression of PR and pS2, which are classical targets of estrogen signaling in breast cancer cells, indicates that in healthy luminal progenitors, estrogen signaling could activate a different network of molecular targets to that it activates in breast cancer cells. The gene discussed is PGR; the disease is breast cancer.